Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial

Cancer/Radiotherapie

Volumn 10, Issue 1-2, 2006, Pages 91-92

  Cuenca, Xavier ^a   Mazeron, Jean Jacques ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

CLINICAL TRIAL; HORMONAL THERAPY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLICATION;

EID: 33645317136     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.01.003     Document Type: Note

References (7)

1. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. The Lancet 2002;360:103-6.
2. Crook JM, Ludgate C, Lim J, Perry G, Malone S, Eapen L, et al. Report of a multicenter canadian phase III randomised trial of 3 vs 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004;60;15-23.
3. D'Amico AV, Manola J, Loffredo M, Renshaw AA, Della Croce A, Kantoff PW. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomised controlled trial. JAMA 2004;292:821-7.
4. Hanks GE, Pajak TF, Porter A, Grignon D, Bereton H, Venkatesan H, et al. Radiation Therapy Oncology Group. Phase III trial of long term androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group 92-02. J. Clin. Oncol. 2003;21:3972-4.
5. Laverdière J, Gomez JL, Cusan L, Suburu ER, Diamond P, Lemay M, et al. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1997;37:247-52.
6. Pilepich MV, Winter K, John MJ, Mesic JB, Sause W, Rubin P, et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 2001;50:1243-52.
7. Pilepich MV, Winter K, Lawton CA, Krisch RE, Wolkov HB, Movsas B, et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - Long term results of phase III RTOG 85-13. Int. J. Radiat. Oncol. Biol. Phys. 2005;61:1285-90.